By following the timing and usage tips in this guide, you are setting yourself up for success
38 The Pharmaceutical Benefits Advisory Committee has recently recommended semaglutide 2.4 mg be listed on the PBS for adults with established cardiovascular disease and BMI 35 kg/m 2 or higher, or 32.5 kg/m 2 or higher for Asian, Aboriginal or Torres Strait Islander populations
Limited Alternatives: There are few pharmaceutical options specifically targeting PCOS-related weight gain, making GLP-1 agonists an attractive option for many
Taking measurements (waist, hips, arms, thighs), progress photos every few weeks, and noting how clothes fit gives you a more complete picture of progress than the scale alone
If youve struggled to achieve sustainable weight loss, our injections may provide the support you need